Boston, MA – The Isosceles Group, an environmental health and safety management firm, is pleased to welcome Haley McClory to the firm.
Haley began her professional life as a researcher, and was given the opportunity to work on relevant projects affecting the world. Her research projects utilized the study of metabolomics, small molecule drug design, and nano-scale drug delivery systems to address treatment and diagnosis of Coronary Artery Disease, Breast Cancer, AIDS, and Alzheimer’s disease. Her research efforts, along with those of her colleagues, culminated in the paper, “Design of novel di-substituted Hydroxy Ureas as inhibitors of Ribonucleotide Reductase,” which addressed a common form of AIDS treatment and its derivatives.
While participating in an International Technology Transfer Institute Clinic, Haley co-authored the paper “Horses as Sources of Proprietary Information: Commercialization, Conservation and Compensation.” This paper addressed relevant international treaties on genetic resources and provided additional support for the hypothesis that developing countries can utilize their rare genetic resources to build capacity within their country.
As a Legal Intern at The Isosceles Group, Haley will be responsible for researching environmental, health, and safety (EHS) laws and regulatory revisions, writing regulatory update articles for the Quarterly Report and the Global Newsletter, and revising EHS protocols.
Haley has a B.S. in Biochemistry and a M.A. in Interdisciplinary Studies, with concentrations in Writing and Business, from Niagara University. She recently received a J.D. from New Hampshire School of Law, where she earned a Certificate in Intellectual Property for her work with trademarks and patents. This coming fall, Haley will be returning to the classroom to pursue a B.S. in Electrical Engineering at the University of New York at Buffalo. She would like it to be noted that, despite what it might look like, she is not collecting degrees.